Wafik El-Deiry: Novel insights into therapy resistance mechanisms downstream of p73
Wafik El-Deiry, Director of Legorreta Cancer Center at Brown University, shared a post on LinkedIn:
“Very pleased to share another long-awaited bioRxiv and medRxiv preprint by El-Deiry Lab group member and Brown University faculty colleagues Dr. Shengliang Zhang and Dr. Lanlan Zhou.
Tumor suppressor p73 transcriptionally regulates c-FLIP to impede its priming of extrinsic apoptosis while a switcher compound degrades c-FLIP protein.
The paper reports novel insights into therapy resistance mechanisms downstream of tumor suppressor p73 and a novel strategy with a new small molecule drug that degrades c-FLIP to address the cancer therapy resistance.
Looking forward to seeing this work progress and get translated to try and help patients.”
Proceed to the article.
Source: Wafik El-Deiry/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023